|
AGTPBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.12749999628903E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6575000039154E-08 |
| Normal-vs-Stage2 |
1.464290E-03 |
| Normal-vs-Stage3 |
1.776880E-04 |
| Normal-vs-Stage4 |
6.539900E-02 |
| Stage1-vs-Stage2 |
4.664800E-01 |
| Stage1-vs-Stage3 |
9.206200E-01 |
| Stage1-vs-Stage4 |
7.253000E-01 |
| Stage2-vs-Stage3 |
5.089200E-01 |
| Stage2-vs-Stage4 |
8.834600E-01 |
| Stage3-vs-Stage4 |
7.344800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22620000212004E-08 |
| Normal-vs-AfricanAmerican |
9.86960000000092E-05 |
| Normal-vs-Asian |
2.123800E-01 |
| Caucasian-vs-AfricanAmerican |
4.213400E-01 |
| Caucasian-vs-Asian |
7.837000E-01 |
| AfricanAmerican-vs-Asian |
9.960200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78600001454754E-09 |
| Normal-vs-Female |
8.593800E-02 |
| Male-vs-Female |
2.156400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.005100E-04 |
| Normal-vs-Extreme_Weight |
9.76549952014238E-11 |
| Normal-vs-Obese |
2.697100E-03 |
| Normal-vs-Extreme_Obese |
1.163940E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.409990E-01 |
| Normal_Weight-vs-Obese |
7.292400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.064000E-01 |
| Extreme_Weight-vs-Obese |
5.087700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.073200E-01 |
| Obese-vs-Extreme_Obese |
6.764200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.530400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.50180000005429E-06 |
| Normal-vs-Age(61-80Yrs) |
3.64270003050393E-09 |
| Normal-vs-Age(81-100Yrs) |
1.46329999994865E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.691800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.549350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.515900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.022400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.485700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.755200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.56110000482101E-08 |
| Normal-VS-Type2 PRCC |
4.79979999967739E-07 |
| Normal-VS-KIRP CIMP |
4.088400E-01 |
| Normal-VS-Unclassified PRCC |
1.602440E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.579200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.178100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.127600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.353500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.588000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.844580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.45619999684044E-08 |
| Normal-vs-N1 |
3.470000E-01 |
| Normal-vs-N2 |
1.825040E-01 |
| N0-vs-N1 |
2.030000E-01 |
| N0-vs-N2 |
8.571800E-01 |
| N1-vs-N2 |
5.396800E-01 |
|
|
